Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2001-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells ; volume:6 ; number:1 ; day:10 ; month:10 ; year:2017 ; pages:1-12 ; date:12.2017
Clinical and translational medicine ; 6, Heft 1 (10.10.2017), 1-12, 12.2017
- Urheber
-
Choi, Wankyu
- Beteiligte Personen und Organisationen
-
Kwon, Soon-Jae
Jin, Hye Jin
Jeong, Sang Young
Choi, Soo Jin
Oh, Wonil
Yang, Yoon Sun
Jeon, Hong Bae
Jeon, Eun Su
SpringerLink (Online service)
- DOI
-
10.1186/s40169-017-0168-z
- URN
-
urn:nbn:de:1111-201711156835
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Choi, Wankyu
- Kwon, Soon-Jae
- Jin, Hye Jin
- Jeong, Sang Young
- Choi, Soo Jin
- Oh, Wonil
- Yang, Yoon Sun
- Jeon, Hong Bae
- Jeon, Eun Su
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
CAPE promotes the expansion of human umbilical cord blood-derived hematopoietic stem and progenitor cells in vitro
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microdrilling combined with high tibial osteotomy for cartilage regeneration
Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells
Hypoxia with Wharton’s jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells
Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells
Optimization of human umbilical cord blood-derived mesenchymal stem cell isolation and culture methods in serum- and xeno-free conditions
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
CAPE promotes the expansion of human umbilical cord blood-derived hematopoietic stem and progenitor cells in vitro
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microdrilling combined with high tibial osteotomy for cartilage regeneration
Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells
Hypoxia with Wharton’s jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells
Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells
Optimization of human umbilical cord blood-derived mesenchymal stem cell isolation and culture methods in serum- and xeno-free conditions
Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
Strategies in umbilical cord-derived mesenchymal stem cells expansion
Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
CAPE promotes the expansion of human umbilical cord blood-derived hematopoietic stem and progenitor cells in vitro
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
Allogeneic umbilical cord blood-derived mesenchymal stem cell implantation versus microdrilling combined with high tibial osteotomy for cartilage regeneration
Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells
Hypoxia with Wharton’s jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells
Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells